BRD4 (Bromodomain-containing protein 4) variants and mutations

BRD4 (also known as Bromodomain-containing protein 4) is a human protein-coding gene encoding a bromodomain-containing protein 4 protein. It remains associated with acetylated chromatin and recruits transcriptional elongation machinery to sustain expression of growth and identity genes. Cancer cells can become highly dependent on BRD4-driven transcription, making it a major target of BET inhibitors and protein degraders. This analysis covers 2,719 BRD4 variants and mutations. Of these, 86% have computational variant effect predictions. Disease context includes Cornelia de Lange syndrome 6, Cornelia de Lange syndrome, and neoplasm. Example BRD4 variants include S2C, S2F, and A3V.

Variant analysis overview

Variant and mutation evidence

Clinical, disease, and population context

Protein structure and variant hotspots

Data sources

Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.

Notable BRD4 variants

Examples include S2C, S2F, A3V, E4*, S5N, G6A, G6S, P7H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.